miDiagnostics’ goal is to enable fast, comprehensive and cost-effective health analysis, regardless of location.
Diagnostic testing is largely dominated by central laboratories, a distance away from the local healthcare settings where patients are tested. There are often delays in receiving results and initiating the correct treatment or referral.

Management Team
The team at miDiagnostics is experienced and dedicated, bringing together research expertise and business acumen, and is united by a desire to see diagnostic systems transform worldwide.

Partnerships
miDiagnostics’ nanoFluidic Processor technology was initially developed by imec, the world-leading R&D and innovation hub in nanoelectronics and digital technologies, together with the expertise of Johns Hopkins University, the leading US research and medical center. Strategic partnerships will continue to be at the heart of our business model.

In addition, miDiagnostics is collaborating with NASA, through its relationship with imec, having been selected to test miDiagnostics’ reader and CBC technology on parabolic test flights that simulate low-gravity environments.

miDiagnostics has also joined US technology company NVIDIA’s Inception program for advanced machine learning implementations.

midIAGNOSTICS - COVID-19 PCR Test Device Brochure

Contact supplier